scanX
Home
Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals

430.20
+15.90
(3.84%)
Market Cap (₹ Cr.)
₹1,109
52 Week High
451.85
Book Value
₹
52 Week Low
273.60
PE Ratio
48.68
PB Ratio
5.92
PE for Sector
38.75
PB for Sector
4.65
ROE
16.82 %
ROCE
15.50 %
Dividend Yield
1.21 %
EPS
₹8.61
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-10.09 %
Net Income Growth
-15.94 %
Cash Flow Change
-24.62 %
ROE
-28.72 %
ROCE
48.52 %
EBITDA Margin (Avg.)
-9.80 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
39
37
33
35
39
40
40
47
30
27
29
38
33
42
44
42
39
46
42
43
30
32
57
58
46
55
60
56
52
61
62
62
58
62
60
50
46
63
Expenses
37
34
31
32
34
38
38
33
29
31
33
40
34
41
42
40
35
43
39
39
28
29
52
51
38
45
50
49
50
57
48
52
50
52
49
44
41
54
EBITDA
2
3
3
2
5
2
2
14
1
-4
-4
-2
-1
1
3
2
4
3
3
3
2
3
5
7
8
10
10
8
1
4
14
10
8
11
11
6
5
8
Operating Profit %
4 %
7 %
7 %
7 %
12 %
6 %
5 %
3 %
1 %
-14 %
-13 %
-5 %
-4 %
3 %
6 %
5 %
9 %
5 %
6 %
6 %
4 %
8 %
9 %
11 %
12 %
17 %
16 %
10 %
2 %
6 %
21 %
14 %
10 %
14 %
14 %
7 %
6 %
11 %
Depreciation
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
1
Interest
1
1
1
1
2
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-0
1
1
0
2
1
1
13
0
-4
-4
-2
-1
1
2
2
4
3
3
3
2
3
5
7
7
10
9
7
0
4
14
10
7
10
10
5
5
7
Tax
-0
0
0
0
0
0
0
3
-1
0
-0
-0
0
0
0
0
1
1
1
1
-0
1
1
1
2
3
3
2
0
2
3
1
2
3
3
1
1
2
Net Profit
0
0
0
0
2
1
1
10
1
-4
-4
-2
-1
1
2
2
3
2
2
2
2
3
4
5
5
7
7
5
0
3
10
8
6
7
7
4
4
5
EPS in ₹
0.03
0.18
0.17
0.13
0.76
0.24
0.19
3.78
0.31
-1.61
-1.47
-0.86
-0.47
0.28
0.68
0.67
1.14
0.76
0.77
0.87
0.59
0.96
1.53
2.07
1.95
2.61
2.51
2.06
0.01
1.12
3.97
2.97
2.14
2.85
2.84
1.48
1.31
1.94
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
154
159
143
130
136
147
164
164
195
217
Fixed Assets
52
52
22
21
22
22
26
23
24
9
Current Assets
96
101
110
95
98
95
120
109
165
199
Capital Work in Progress
0
0
0
3
4
4
0
0
0
0
Investments
0
0
0
0
0
11
15
51
1
0
Other Assets
102
108
121
105
110
109
123
91
170
208
Total Liabilities
59
61
33
32
31
36
42
31
36
30
Current Liabilities
55
57
29
29
28
33
40
27
28
19
Non Current Liabilities
4
4
3
3
3
3
2
4
8
11
Total Equity
95
98
110
98
104
111
122
133
159
187
Reserve & Surplus
82
85
97
85
91
98
109
120
146
174
Share Capital
13
13
13
13
13
13
13
13
13
13
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
1
5
-6
24
-0
19
-36
-11
2
Investing Activities
-0
-2
41
-3
-1
-11
-2
-26
-58
-25
Operating Activities
4
9
-3
-2
31
11
28
7
47
35
Financing Activities
-1
-6
-34
-1
-6
-1
-7
-18
-0
-9
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
70.34 %
70.34 %
70.34 %
70.34 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.48 %
68.09 %
68.04 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.37 %
0.38 %
0.53 %
0.73 %
1.10 %
DIIs
0.00 %
0.00 %
0.12 %
0.20 %
0.67 %
0.68 %
0.41 %
0.88 %
0.92 %
0.83 %
0.83 %
0.82 %
0.85 %
0.85 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.65 %
29.65 %
29.54 %
29.46 %
30.61 %
30.61 %
30.87 %
30.41 %
30.36 %
30.08 %
30.08 %
30.17 %
30.33 %
30.01 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
Cipla
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
Dr Reddys Laboratories
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
Zydus Life Science
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
Mankind Pharma
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
Lupin
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
Aurobindo Pharma
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
Alkem Laboratories
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
Glenmark Pharmaceuticals
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20
Biocon
370.65 43,587.78 27.93 15,621.20 35.25 1,298 478.78 51.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
63.57
ATR(14)
Volatile
17.33
STOCH(9,6)
Neutral
77.30
STOCH RSI(14)
Neutral
60.75
MACD(12,26)
Bearish
-0.17
ADX(14)
Weak Trend
14.19
UO(9)
Bearish
50.49
ROC(12)
Uptrend And Accelerating
5.53
WillR(14)
Overbought
-7.05
Bearish
3
Neutral
5
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.